Compare ODC & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ODC | THQ |
|---|---|---|
| Founded | 1941 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Finance Companies |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 995.6M | 798.8M |
| IPO Year | 1994 | N/A |
| Metric | ODC | THQ |
|---|---|---|
| Price | $62.89 | $18.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 61.1K | ★ 121.0K |
| Earning Date | 03-18-2026 | 01-01-0001 |
| Dividend Yield | 1.30% | ★ 7.53% |
| EPS Growth | ★ 50.45 | N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $485,572,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $37.40 | ★ N/A |
| Revenue Growth | ★ 10.97 | N/A |
| 52 Week Low | $41.37 | $15.14 |
| 52 Week High | $70.01 | $21.07 |
| Indicator | ODC | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 51.05 | 31.69 |
| Support Level | $58.16 | $17.68 |
| Resistance Level | $66.83 | $18.36 |
| Average True Range (ATR) | 1.91 | 0.26 |
| MACD | -0.55 | -0.08 |
| Stochastic Oscillator | 25.95 | 22.48 |
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.